12:00 AM
 | 
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Deals

GenVec, Novartis deal

GenVec said in its 4Q12 earnings that it extended by one year through January 2014 a 2010 deal granting the pharma exclusive, worldwide rights to GenVec's...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >